| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 70966 |
四(4-甲氧基苯基)卟啉T(4-MOP)P |
110 |
WYQ |
2024-12-24 |
| 70967 |
DOPG:DOPC:Chol-ATP Liposome,DOPG:DOPC:胆固醇-三磷酸腺苷脂质体 |
174 |
axc |
2024-12-24 |
| 70968 |
2-氯甲基-5,10,15,20-四苯基卟啉(TPP-CH2Cl) |
146 |
WYQ |
2024-12-24 |
| 70969 |
Maleimide-NH-PEG4-CH2CH2COONHS Ester cas:756525-99-2 |
103 |
zyl |
2024-12-24 |
| 70970 |
DOPG:Chol-ATP Liposome,DOPG:胆固醇-三磷酸腺苷脂质体 |
152 |
axc |
2024-12-24 |
| 70971 |
DOTAGlu-C(AGADPL)2,250612-06-7，多肽，DOTA-RGD探针二聚体 |
93 |
kx |
2024-12-24 |
| 70972 |
sulfo-SPDB，1193111-39-5，抗体- 药物偶联物 |
69 |
hyy |
2024-12-24 |
| 70973 |
H2N-PEG8-OH cas:352439-37-3 氨基-八聚乙二醇-羟基 |
76 |
zyl |
2024-12-24 |
| 70974 |
α,α,α,β-四-[邻(叔丁氧羰丙氨酸)氨基苯基]卟啉H2T(o-BocAla)APP |
154 |
WYQ |
2024-12-24 |
| 70975 |
HS-PEG8-CH2CH2COOH cas:866889-02-3 巯基-八聚乙二醇-丙酸 |
99 |
zyl |
2024-12-24 |
| 70976 |
DOTA-PEG-CRGD，大环化合物 |
113 |
kx |
2024-12-24 |
| 70977 |
NO2-SPDB-sulfo CAS:663598-89-8 |
104 |
h |
2024-12-24 |
| 70978 |
DOTAP:DOPC:Chol:PEG2000-ATP Liposome (PEGylated),DOTAP:DOPC:Chol:PEG2000-ATP脂质体(聚乙二醇化) |
102 |
axc |
2024-12-24 |
| 70979 |
Py-ds-dmBut-amido-PEG4-NHS ester |
102 |
h |
2024-12-24 |
| 70980 |
HO-PEG6-CH2CH2COOH 羟基-六聚乙二醇-丙酸 |
98 |
zyl |
2024-12-24 |
| 70981 |
Ald-Ph-amido-PEG2 CAS:1061569-06-9 |
66 |
h |
2024-12-24 |
| 70982 |
DOTA-E-[c(RGDfK)]2，大环化合物 |
69 |
kx |
2024-12-24 |
| 70983 |
mPEG11-CH2CH2COOtBu的介绍 |
89 |
zyl |
2024-12-24 |
| 70984 |
Boc-Val-Ala-PAB-PNP CAS:1884578-00-0 |
82 |
h |
2024-12-24 |
| 70985 |
5,10,15,20-四（4-月桂酰氨基苯基）卟啉(TLAPP) |
110 |
|
2024-12-24 |
| 70986 |
Amino-PEG8-Boc CAS:756526-06-4 |
97 |
h |
2024-12-24 |
| 70987 |
DOTAP:Chol:PEG2000-ATP Liposome (PEGylated),DOTAP:Chol:PEG2000-ATP脂质体(聚乙二醇化) |
88 |
axc |
2024-12-24 |
| 70988 |
Ga-DOTA-FAPI/ANCP-PSMA，大环化合物 |
110 |
kx |
2024-12-24 |
| 70989 |
5,10,15,20-四(4-甲氧羰基苯基)卟啉(TCMPP) |
112 |
WYQ |
2024-12-24 |
| 70990 |
N3-PEG4-C2-Pfp ester CAS:1353012-00-6 |
73 |
h |
2024-12-24 |
| 70991 |
mPEG40-OH cas:1346556-95-3 甲氧基四十聚乙二醇-羟基 |
80 |
zyl |
2024-12-24 |
| 70992 |
PC:Chol:PEG2000-ATP Liposome (PEGylated),PC:Chol:PEG2000-ATP脂质体(聚乙二醇化) |
121 |
axc |
2024-12-24 |
| 70993 |
perfluorophenyl 4-(pyridin-2-yldisulfanyl)butanoate ，PDB-PFP，2088570-81-2，ADC试剂 |
78 |
hyy |
2024-12-24 |
| 70994 |
Ald-Ph-amido-PEG3-C1-Boc CAS:1007215-94-2 |
65 |
h |
2024-12-24 |
| 70995 |
2 5 8 11-Tetraoxaheptadecane-17-thiol cas:205490-80-8 |
117 |
zyl |
2024-12-24 |
| 70996 |
72573-82-1，Gd-DOTA，钆特酸，大环化合物 |
93 |
kx |
2024-12-24 |
| 70997 |
PS:PC:Chol:PEG2000-ATP Liposome (PEGylated),PS:PC:Chol:PEG2000-ATP脂质体(聚乙二醇化) |
146 |
axc |
2024-12-24 |
| 70998 |
mPEG45-SSG的结构式 |
95 |
zyl |
2024-12-24 |
| 70999 |
DOTA satoreotide，大环化合物 |
81 |
kx |
2024-12-24 |
| 71000 |
PS:PC:Chol:PEG2000-ATP Liposome (PEGylated),PS:PC:Chol:PEG2000-ATP脂质体(聚乙二醇化) |
148 |
axc |
2024-12-24 |
| 71001 |
mPEG62-OH 甲氧基六二聚乙二醇-羟基 |
115 |
zyl |
2024-12-24 |
| 71002 |
DOTA-甲基四嗪,1610950-41-8，DOTA-多肽分子探针 |
65 |
kx |
2024-12-24 |
| 71003 |
mPEG45-OH 甲氧基四十五聚乙二醇-羟基 |
105 |
zyl |
2024-12-24 |
| 71004 |
DOPG:DOPC:Chol:PEG2000-ATP Liposome (PEGylated),DOPG:DOPC:胆固醇:聚乙二醇2000-ATP脂质体(聚乙二醇化) |
161 |
axc |
2024-12-24 |
| 71005 |
2,5-Dioxo-1-(4-(pyridin-2-yldisulfanyl)butanoyloxy)pyrrolidine-3-sulfonic acid，SPDB-sulfo，1628113-16-5，抗体- 药物偶联物 |
66 |
hyy |
2024-12-24 |
| 71006 |
5-(4-羧基苯基)-10,15,20-四苯基镁卟啉（MgTPPCOOH） |
83 |
WYQ |
2024-12-24 |
| 71007 |
mPEG1-OCH2CH2COONHS Ester cas:1127247-34-0 |
79 |
zyl |
2024-12-24 |
| 71008 |
1610950-41-8,DOTA-MeTz，DOTA-甲基四嗪，大环化合物 |
88 |
kx |
2024-12-24 |
| 71009 |
橙红色固体5,15-二(4-乙炔基苯基)-10,20-二苯基钴卟啉（CoDETPP） |
92 |
WYQ |
2024-12-24 |
| 71010 |
原卟啉二甲酯钴配合物PPDMECo |
77 |
WYQ |
2024-12-24 |
齐岳微信公众号
官方微信
库存查询